Clinical trial
Comparative Oral Bioavailability Study of MT-1303
NCT02310048
Study timeline
Study start (unknown)2014-11-01Date precision: month
Registry last updated2015-03-17
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Relapsing-remitting Multiple Sclerosisunresolved
Interventions
MT-1303-FormADRUG
MT-1303-FormBDRUG
Sponsors & collaborators
Tanabe Pharma Corporationlead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02310048 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.